Estrogen plus progestin and risk of benign proliferative breast disease.
Rohan TE, Negassa A, Chlebowski RT, Lasser NL, McTiernan A, Schenken RS, Ginsberg M, Wassertheil-Smoller S, Page DL.
Rohan TE, et al. Among authors: page dl.
Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2337-43. doi: 10.1158/1055-9965.EPI-08-0380. Epub 2008 Aug 25.
Cancer Epidemiol Biomarkers Prev. 2008.
PMID: 18725513
Free PMC article.
Clinical Trial.